Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
Open Access
- 1 September 2010
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 59 (9) , 2087-2093
- https://doi.org/10.2337/db10-0630
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN–JDRF Type 1 Diabetes Combination Therapy Assessment GroupClinical and Experimental Immunology, 2010
- Antigen-dependent immunotherapy of non-obese diabetic mice with immature dendritic cellsClinical and Experimental Immunology, 2010
- Foxp3+ T Cells Induce Perforin-Dependent Dendritic Cell Death in Tumor-Draining Lymph NodesPublished by Elsevier ,2010
- Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetesClinical and Experimental Immunology, 2009
- Peptide immunotherapy in allergic asthma generates IL-10–dependent immunological tolerance associated with linked epitope suppressionThe Journal of Experimental Medicine, 2009
- Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety studyClinical and Experimental Immunology, 2008
- Increased resistance to CD4+CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetesClinical and Experimental Immunology, 2008
- GAD Treatment and Insulin Secretion in Recent-Onset Type 1 DiabetesNew England Journal of Medicine, 2008
- Plasmacytoid Dendritic Cells Mediate Oral ToleranceImmunity, 2008
- Translational Mini-Review Series on Type 1 Diabetes: Immune-based therapeutic approaches for type 1 diabetesClinical and Experimental Immunology, 2007